NDC 36987-1234

Oyster

Oyster

Oyster is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Oyster.

• Product ID: 36987-1234_7c6e2716-24f3-4479-abfc-901a69fc08d9
• NDC: 36987-1234
• Product Type: Human Prescription Drug
• Proprietary Name: Oyster
• Generic Name: Oyster
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1972-08-29
• Marketing Category: BLA / BLA
• Application Number: BLA102192
• Labeler Name: Nelco Laboratories, Inc.
• Substance Name: OYSTER
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Shellfish Proteins [EXT]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 36987-1234-2

10 mL in 1 VIAL, MULTI-DOSE (36987-1234-2)

• Marketing Start Date: 1972-08-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 36987-1234-3 [36987123403]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1234-1 [36987123401]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1234-4 [36987123404]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1234-2 [36987123402]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
OYSTER	.05 g/mL

OpenFDA Data

• SPL SET ID: 26081998-16db-41f6-b366-3fd7007b99de
• Manufacturer:
  • Nelco Laboratories, Inc.
• UNII:
  • BKZ683617P
  • 76780GX08D
  • 7062I37LB3
  • ZB2SV6JJY5
  • 0WLY635722
  • 01695YPV36
  • WF621S7K14
  • 5JKY494U4L
• RxNorm Concept Unique ID - RxCUI:
  • 905477
  • 899749
  • 901286
  • 901377
  • 966679
  • 900034
  • 905339
  • 905335
  • 905331
  • 901268
  • 905352
  • 899431
  • 901379
  • 899437
  • 899412
  • 966976
  • 905487
  • 905482
  • 899919
  • 905363
  • 901393
  • 905327

Pharmacological Class

• Non-Standardized Food Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Dietary Proteins [CS]
• Shellfish Proteins [EXT]

NDC Crossover Matching brand name "Oyster" or generic name "Oyster"

NDC	Brand Name	Generic Name
0268-6189	OYSTER	EASTERN OYSTER
22840-5774	Oyster	Crassostrea virginica
36987-1234	Oyster	Oyster
36987-1235	Oyster	Oyster
36987-1236	Oyster	Oyster
36987-1237	Oyster	Oyster
49288-0336	Oyster	Oyster